Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions
- PMID: 12788795
- DOI: 10.1182/blood-2003-03-0780
Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions
Comment on
-
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.Blood. 2003 Mar 1;101(5):2067-9. doi: 10.1182/blood-2002-07-2110. Epub 2002 Oct 24. Blood. 2003. PMID: 12406871
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

